CAS 192185-72-1: Tipifarnib
Description:Tipifarnib, with the CAS number 192185-72-1, is a synthetic organic compound classified as a farnesyltransferase inhibitor. It is primarily investigated for its potential therapeutic applications in oncology, particularly for treating certain types of cancer, including hematologic malignancies and solid tumors. The compound works by inhibiting the farnesylation process, which is crucial for the proper functioning of several oncogenic proteins, thereby disrupting cancer cell proliferation and survival. Tipifarnib is characterized by its specific molecular structure, which includes a farnesyl moiety, contributing to its mechanism of action. It is typically administered in a clinical setting and has undergone various phases of clinical trials to evaluate its efficacy and safety profile. As with many investigational drugs, its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are critical for understanding its therapeutic potential and optimizing treatment regimens. Overall, Tipifarnib represents a targeted approach in cancer therapy, focusing on molecular pathways involved in tumor growth and progression.
Formula:C27H22Cl2N4O
InChI:InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1
InChI key:InChIKey=PLHJCIYEEKOWNM-HHHXNRCGSA-N
SMILES:O=C1C=C(C=2C=CC=C(Cl)C2)C=3C=C(C=CC3N1C)C(N)(C4=CC=C(Cl)C=C4)C5=CN=CN5C
- Synonyms:
- (R)-(+)-R 115777
- (R)-6-(Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone
- 2(1H)-Quinolinone, 6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-
- 6-[(R)-Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone
- 6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2(1H)-one
- Tipifarnib Zarnestra
- Zarnestra
- Tipifarnib